BPRN

Princeton Bancorp is a ~$2.29B-asset state commercial bank whose FY2025 headline looks explosive — net income $18.6M (+81.7%) and diluted EPS $2.71 (+74.8%) — but the growth is optical, measured off a depressed FY2024 trough of $10.2M. Seen across the full cycle (FY2021 $22.5M, FY2022 $26.5M, FY2023 $25.8M), 2025 earnings have merely recovered part-way and still sit below the pre-2024 run-rate. The defining number is return on equity of 6.9%, which is well below what a healthy bank earns (roughly 10-12%) and below a reasonable cost of equity — this is a low-return franchise, not a compounder. Total assets shrank 2.4% and liabilities fell 3.1%, so the balance sheet is contracting rather than growing.

The quality and safety side is reassuring, which is what keeps this from being a sell. The auditor issued an unqualified opinion on both the financials and internal controls (PCAOB ID 392), the sole critical audit matter is the routine CECL allowance for credit losses of $20.3M — standard for a bank, not a red flag. Leverage of 7.44x liabilities/equity is normal for the industry, long-term debt is effectively nil, cash grew 15.6% to $136M, and operating cash flow rose 45.9% to $21.5M against trivial $0.9M capex. Capital return is aggressive and shareholder-friendly: $8.66M of dividends plus $7.87M of buybacks (up 834%) returned ~89% of net income, and because the stock trades around book value those repurchases are roughly value-neutral-to-accretive.